Acadia Healthcare Q4 revenue $593.5M, adjusted EPS $0.81; guides 2022 rev $2.55-2.60B

Acadia Healthcare Company, Inc.

2021-FY EPS reported $2.10 revenue$2,314,394,000

Q4 revenue $593.5M, same facility +10.7%; adjusted EBITDA $156.1M.
Net income $70.3M ($0.77 diluted); adjusted EPS $0.81 ($0.67 ex-PRF).
Acquired CenterPointe Behavioral Health for $139M cash on Dec 31, 2021.
2022 guidance: rev $2.55-2.60B, adj. EBITDA $575-610M, adj. EPS $2.85-3.15.
Opened five new CTCs in Q4; plans 6-10 in 2022; announced three new JV partnerships.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.